Join us for a webinar hosted by The Antibody Society and mAbs, where Dr. Crescioli and Dr. Reichert will provide an overview of the most important antibody therapeutics expected in 2025. This session will include insights into 2024’s antibody approvals, the latest candidates in regulatory review, and trends in bispecific antibodies and ADCs.
Speakers:
- Dr. Silvia Crescioli: Business Intelligence Creator, The Antibody Society.
- Dr. Janice Reichert: Director of Business Intelligence, The Antibody Society.
Key Takeaways:
- Trends shaping antibody therapeutics in 2025
- Success rates for bispecifics and ADCs
- Projections for upcoming antibody approvals
Register today to secure your spot!
Note: The webinar platform and registration process is managed by Community Brands.
Their privacy policy is here.
Our selection of On Demand webinars can be viewed here.
Our YouTube channel includes selected webinars as well as recordings of our Symposia on topics such as:
- Computational Antibody Discovery: State of the Art
- Biopharmaceutical Informatics
- Harnessing Cytokines for Cancer Immunotherapy
- Emerging Immunotherapeutics for Ovarian Cancer Symposium
- Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells
